FDA approves landmark pancreatic cancer drug that's shown to improve survival
Aug 26, 09:31 PM
Share
Subscribe
AP correspondent Ed Donahue reports on a new drug for people with pancreatic cancer.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.